Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
In the latest session, Rockwell Medical Inc (NASDAQ: RMTI) closed at $1.21 down -0.82% from its previous closing price of $1.22. In other words, the price has decreased by -$0.82 from its previous closing price. On the day, 0.7 million shares were traded. RMTI stock price reached its highest trading level at $1.21 during the session, while it also had its lowest trading level at $1.17.
Ratios:
For a deeper understanding of Rockwell Medical Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.26 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.55. For the most recent quarter (mrq), Quick Ratio is recorded 2.51 and its Current Ratio is at 2.89. In the meantime, Its Debt-to-Equity ratio is 0.46 whereas as Long-Term Debt/Eq ratio is at 0.37.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on November 14, 2024, initiated with a Buy rating and assigned the stock a target price of $5.
On June 24, 2019, Piper Jaffray started tracking the stock assigning a Overweight rating and target price of $10.
On May 13, 2019, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $11.H.C. Wainwright initiated its Buy rating on May 13, 2019, with a $11 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Oct 01 ’25 when Neri Jesse bought 886 shares for $1.15 per share.
Chole Timothy sold 2,868 shares of RMTI for $3,413 on Oct 01 ’25. The SVP and CCO now owns 125,299 shares after completing the transaction at $1.19 per share. On Oct 01 ’25, another insider, Neri Jesse, who serves as the SVP and CFO of the company, sold 886 shares for $1.19 each. As a result, the insider received 1,054 and left with 125,728 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RMTI now has a Market Capitalization of 41660728 and an Enterprise Value of 37245724. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.47 while its Price-to-Book (P/B) ratio in mrq is 1.37. Its current Enterprise Value per Revenue stands at 0.423 whereas that against EBITDA is 41.569.
Stock Price History:
The Beta on a monthly basis for RMTI is 1.68, which has changed by -0.64411765 over the last 52 weeks, in comparison to a change of 0.1719923 over the same period for the S&P500. Over the past 52 weeks, RMTI has reached a high of $5.15, while it has fallen to a 52-week low of $0.78. The 50-Day Moving Average of the stock is -5.84%, while the 200-Day Moving Average is calculated to be -12.39%.
Shares Statistics:
For the past three months, RMTI has traded an average of 1.43M shares per day and 802110 over the past ten days. A total of 34.43M shares are outstanding, with a floating share count of 28.94M. Insiders hold about 15.94% of the company’s shares, while institutions hold 17.11% stake in the company. Shares short for RMTI as of 1757894400 were 1545437 with a Short Ratio of 1.08, compared to 1755216000 on 175071. Therefore, it implies a Short% of Shares Outstanding of 1545437 and a Short% of Float of 5.07.
Earnings Estimates
The dynamic stock of Rockwell Medical Inc (RMTI) is currently attracting attention from 2.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is -$0.05, with high estimates of -$0.04 and low estimates of -$0.05.
Analysts are recommending an EPS of between -$0.17 and -$0.18 for the fiscal current year, implying an average EPS of -$0.17. EPS for the following year is -$0.13, with 2.0 analysts recommending between -$0.09 and -$0.17.
Revenue Estimates
A total of 2 analysts believe the company’s revenue will be $16.24M this quarter.It ranges from a high estimate of $16.8M to a low estimate of $15.69M. As of. The current estimate, Rockwell Medical Inc’s year-ago sales were $28.32MFor the next quarter, 2 analysts are estimating revenue of $17.15M. There is a high estimate of $18.13M for the next quarter, whereas the lowest estimate is $16.17M.
A total of 2 analysts have provided revenue estimates for RMTI’s current fiscal year. The highest revenue estimate was $69.91M, while the lowest revenue estimate was $66.84M, resulting in an average revenue estimate of $68.37M. In the same quarter a year ago, actual revenue was $101.49MBased on 2 analysts’ estimates, the company’s revenue will be $75.89M in the next fiscal year. The high estimate is $81.59M and the low estimate is $70.18M.
